Hematological abnormalities in liver cirrhosis.

Area of Science:

• Hepatology
• Hematology
• Internal Medicine

Background:

• Hematological abnormalities, including thrombocytopenia, leukopenia, and anemia, are prevalent in cirrhosis patients.
• These abnormalities significantly influence clinical decisions regarding invasive procedures, infection, and bleeding risks.
• The hemostatic balance in cirrhosis is complex, involving both procoagulant and anticoagulant factors, challenging traditional views of bleeding predisposition.

Purpose of the Study:

• To review hematologic abnormalities in liver cirrhosis.
• To elucidate the mechanisms of hemostasis, coagulation, and fibrinolysis in cirrhosis.
• To discuss the limitations of laboratory testing and clinical manifestations of bleeding and thrombosis.

Main Methods:

• Comprehensive literature review of hematological abnormalities in cirrhosis.
• Analysis of pathophysiological mechanisms underlying hemostasis dysregulation.
• Examination of clinical implications and diagnostic challenges.

Main Results:

• High prevalence of thrombocytopenia (77.9%), leukopenia (23.5%), and anemia (21.1%) in compensated cirrhosis.
• Cirrhosis patients exhibit a complex hemostatic phenotype with both bleeding and thrombotic risks.
• Thrombotic complications are more common in decompensated cirrhosis and linked to disease severity.

Conclusions:

• Hematologic abnormalities are integral to cirrhosis pathophysiology and patient outcomes.
• Routine laboratory tests inadequately capture the complex hemostatic profile in cirrhosis.
• A thorough understanding of these hematologic and hemostatic derangements is essential for managing cirrhosis patients effectively.